Zhejiang Tailin Bioengineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021
April 25, 2021 at 01:45 pm IST
Share
Zhejiang Tailin BioEngineering Co.,Ltd announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 48.043 million compared to CNY 40.755 million a year ago. Operating income was CNY 10.868 million compared to CNY 8.500 million a year ago. Net income was CNY 9.598 million compared to CNY 7.347 million a year ago. Basic earnings per share from continuing operations was CNY 0.18 compared to CNY 0.15 a year ago.
Zhejiang Tailin Bioengineering Co., Ltd. is a China-based company mainly engaged in pharmaceutical equipment business. The Company's main business is the research, development, manufacturing and sales of microbial detection and control technology system products, organic substance analysis instruments and other pharmaceutical equipment. Specific products include various consumables, instruments and equipment, which can be used alone or in combination for the production and quality of sterile drugs. The application areas that can be expanded include medical and health, food safety, disease prevention and control, biosecurity, inspection and quarantine, biological engineering, laboratory animals, and environmental protection. The Company distributes its products within domestic market and to overseas markets.
ZHEJIANG TAILIN BIOENGINEERING CO.,LTD 
